Abound Wealth Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $962 | Hold |
54
| – | – | ﹤0.01% | 806 |
|
|
2025
Q1 | $963 | Hold |
54
| – | – | ﹤0.01% | 764 |
|
|
2024
Q4 | $1.61K | Hold |
54
| – | – | ﹤0.01% | 689 |
|
|
2024
Q3 | $845 | Hold |
54
| – | – | ﹤0.01% | 796 |
|
|
2024
Q2 | $926 | Hold |
54
| – | – | ﹤0.01% | 736 |
|
|
2024
Q1 | $845 | Hold |
54
| – | – | ﹤0.01% | 793 |
|
|
2023
Q4 | $807 | Hold |
54
| – | – | ﹤0.01% | 814 |
|
|
2023
Q3 | $873 | Hold |
54
| – | – | ﹤0.01% | 725 |
|
|
2023
Q2 | $2.24K | Hold |
54
| – | – | ﹤0.01% | 632 |
|
|
2023
Q1 | $3.25K | Hold |
54
| – | – | ﹤0.01% | 509 |
|
|
2022
Q4 | $3.96K | Hold |
54
| – | – | ﹤0.01% | 391 |
|
|
2022
Q3 | $4.1K | Buy |
+54
| New | +$4.1K | ﹤0.01% | 388 |
|